Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2016-06-01
DOI
10.1155/2016/3072586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3 – LBA, biomarkers and immunogenicity)
- (2015) Lakshmi Amaravadi et al. Bioanalysis
- Development of a Method That Eliminates False-Positive Results due to Nerve Growth Factor Interference in the Assessment of Fulranumab Immunogenicity
- (2014) Sheng Dai et al. AAPS Journal
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- Evolution and Emergence of Therapeutic Monoclonal Antibodies
- (2013) Ian N. Foltz et al. CIRCULATION
- Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
- (2013) Brian Baldo OncoImmunology
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
- (2012) Anke Vennegoor et al. Multiple Sclerosis Journal
- A Survey of Applications of Biological Products for Drug Interference of Immunogenicity Assays
- (2012) Yow-Ming C. Wang et al. PHARMACEUTICAL RESEARCH
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential effect of drug interference in immunogenicity assays
- (2011) Margreet H. Hart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
- (2011) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months
- (2010) Begoña Oliver et al. Multiple Sclerosis Journal
- Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
- (2009) Rafael Ponce et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Considerations for the development of therapeutic monoclonal antibodies
- (2008) Patrick G Swann et al. CURRENT OPINION IN IMMUNOLOGY
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now